YAP1 and neoplasm: Mechanistically, following anti-PD-1 treatment, IFN-γ induces phase separation of YAP in tumor cells, thereby establishing a transcriptional hub that recruits multiple epigenetic modifiers to amplify the expression of targets (such as CD155), ultimately promoting anti-PD-1 resistance [133].